Occudo Quantitative Strategies LP Avenue Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $542 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$1.48 - $2.65 $21,309 - $38,154
-14,398 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.41 - $7.11 $34,699 - $102,369
14,398 New
14,398 $36,000

About AVENUE THERAPEUTICS, INC.

ATXI Quotes by TradingView
  • Ticker ATXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,127,720
  • Market Cap $9.25M
  • Description
  • Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...
More about ATXI
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email